spacer
home > pmps > summer 2017 > heating up
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Heating Up

One cannot complain that cold chain for the pharmaceutical and biotechnology industries is lacking challenges shipping products globally by airplanes or ocean freighters, for instance, is a hot discussion topic. This obstacle is not new for products and vaccines shipped in the 2-8C range, but for other expanses, like 15-25C, it has a considerable impact.

Almost 50% of temperature excursions take place on the tarmac of an airport; thus, a compliant shipment is important. The only way to maintain product quality is to keep it in prescribed conditions until the moment of use. No patient can benefit from an expired treatment or an inaccurate blood sugar level measurement because the strips were not kept in the right conditions. Even worse, products could become harmful instead of helpful.

From a cost perspective, as well as a qualitative one, the use of ocean freight is transcending that of air transport. Ocean shipping is not only considered for low-value products, but also for high-value ones, such as vaccines.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Martin Gouda is a Partner of Supply Chain Strategies at Buck Consultants International and has over 30 years of experience in international supply chain optimisation. He has worked in various roles at the strategic and tactical level in management and consultancy. Martin worked for a global 3PL for almost 10 years in various business development positions. In this period, he was responsible for breakthrough and step change projects with pharma companies. In the last three years, he was leading the healthcare sector on a global level. Martin is co-founder and board member of the Healthcare Logistics Forum. 
spacer
Martin Gouda
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

York Health Economics Consortium offers a new health utilities training course

Cost-utility analysis is a requirement for NICE health technology appraisals and is being increasingly used in other contexts and countries. Health utilities, a crucial component of cost-utility analysis, capture the relative change in health-related quality of life resulting from a treatment. As such, health utility can be a key driver of the cost-effectiveness ratio. Obtaining health utility values that are suitable for your economic evaluation, however, may not always be straight forward.
More info >>

White Papers

Successfully managing the unique demands of cell therapy supply chains

PCI Pharma Services

Cell therapy professionals joined a specialist webinar by industry experts from PCI Clinical Services and TrakCel, addressing the unique complexity of an autologous therapy supply chain. Hosted by European Pharmaceutical Manufacturer magazine, the webinar was delivered by Rachel Griffiths, Associate Director, Technical Services, PCI Clinincal Services, and Dr. Matthew Lakelin, Vice President, Scientific Affairs and Business Development, TrakCel . Here, we present the white paper from that webinar event.
More info >>

 
Industry Events

PHARM Connect Congress 2018

13-14 March 2018, Corinthia Hotel Budapest, Hungary

PHARM Connect Congress is the premier networking business event dedicated to pharmaceutical and biotechnology innovations and trends from development through commercialization in Central and Eastern Europe and the CIS region. The two days event offers the perfect setting for solution providers to present their products and services directly to key decision makers playing a key role in the pharmaceutical industry in Central Eastern Europe.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement